Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
AIDS Research and Human Retroviruses|February 25, 2011
Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South AfricaBarbara S Taylor, Gillian Hunt, Elaine J Abrams, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|February 23, 2017
Mobility and Clinic Switching Among Postpartum Women Considered Lost to HIV Care in South AfricaKate Clouse, Sten H Vermund, Mhairi Maskew, et al.AIDS (London, England)|May 7, 2009
Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapyKelly Smith, Louise Kuhn, Ashraf Coovadia, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 25, 2011
Induction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in childrenAnitha Moorthy, Louise Kuhn, Ashraf Coovadia, et al.JAMA|September 9, 2010
Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trialAshraf Coovadia, Elaine J Abrams, Renate Stehlau, et al.Journal of the International AIDS Society|October 9, 2024
Are social protection and food security accelerators for adolescents to achieve the Global AIDS targets?Lucie Cluver, Siyanai Zhou, Olanrewaju Edun, et al.Southern African Journal of HIV Medicine|March 24, 2018
How ready are our health systems to implement prevention of mother to child transmission Option B+?Palesa Nkomo, Natasha Davies, Gayle Sherman, et al.BMC Infectious Diseases|September 19, 2019
Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13Gillian M Hunt, Johanna Ledwaba, Anna Salimo, et al.The Lancet. Infectious Diseases|March 20, 2012
Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trialLouise Kuhn, Ashraf Coovadia, Renate Strehlau, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 13, 2009
Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapyAshraf Coovadia, Gillian Hunt, Elaine J Abrams, et al.Pageof 5